[B01AD01, streptokinase, The therapeutic efficacy of Streptokinase can be decreased when used in combination with Cefixime.]
[B01AE07, dabigatran etexilate, The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Cefixime.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Tetracaine.]
[B01AD04, urokinase, The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefixime.]
[B01AF01, rivaroxaban, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Cefixime.]
[B01AC24, ticagrelor, The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Cefixime.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Cefixime is combined with Warfarin.]
[B01AE01, desirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.]
[B01AX01, defibrotide, The therapeutic efficacy of Defibrotide can be decreased when used in combination with Cefixime.]
[B01AF02, apixaban, The therapeutic efficacy of Apixaban can be decreased when used in combination with Cefixime.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Benzyl alcohol.]
[B01AE03, argatroban, The therapeutic efficacy of Argatroban can be decreased when used in combination with Cefixime.]
[B01AC26, vorapaxar, The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefixime.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Cefixime is combined with Acenocoumarol.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Cefixime is combined with Dicoumarol.]
[B01AF03, edoxaban, The therapeutic efficacy of Edoxaban can be decreased when used in combination with Cefixime.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Cefixime is combined with Tioclomarol.]
[B01AC25, cangrelor, The therapeutic efficacy of Cangrelor can be decreased when used in combination with Cefixime.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Oxybuprocaine.]
[B01AF04, betrixaban, The therapeutic efficacy of Betrixaban can be decreased when used in combination with Cefixime.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Capsaicin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Chloroprocaine.]
[B01AE02, lepirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Dyclonine.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefixime.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Cocaine.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be decreased when used in combination with Cefixime.]
[M03AC11, cisatracurium, Cefixime may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Cefixime.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Cinchocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Diphenhydramine.]
[B01AC07, dipyridamole, The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Cefixime.]
[B01AD10, drotrecogin alfa, The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Cefixime.]
[P03AA04, disulfiram, The risk or severity of adverse effects can be increased when Cefixime is combined with Disulfiram.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Ropivacaine.]
[B01AC18, triflusal, The therapeutic efficacy of Triflusal can be decreased when used in combination with Cefixime.]
[C05CA04, troxerutin, The therapeutic efficacy of Troxerutin can be decreased when used in combination with Cefixime.]
[B01AD03, anistreplase, The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefixime.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Etidocaine.]
[B05AA05, dextran, The therapeutic efficacy of Dextran can be decreased when used in combination with Cefixime.]
[B01AD05, plasmin, The therapeutic efficacy of Fibrinolysin can be decreased when used in combination with Cefixime.]
[C03CA01, furosemide, Furosemide may decrease the excretion rate of Cefixime which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Cefixime is combined with Fluindione.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Cefixime.]
[B05CB02, sodium citrate, The therapeutic efficacy of Sodium citrate can be decreased when used in combination with Cefixime.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Articaine.]
[B01AE06, bivalirudin, The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefixime.]
[B01AC22, prasugrel, The therapeutic efficacy of Prasugrel can be decreased when used in combination with Cefixime.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Cefixime.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Lidocaine.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefixime.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Cefixime.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be decreased when used in combination with Cefixime.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Mepivacaine.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be decreased when used in combination with Cefixime.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Cefixime.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be decreased when used in combination with Cefixime.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefixime.]
[B01AD09, ancrod, The therapeutic efficacy of Ancrod can be decreased when used in combination with Cefixime.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be decreased when used in combination with Cefixime.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Cefixime is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Cefixime is combined with Phenprocoumon.]
[B01AC13, abciximab, The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefixime.]
[S01XA13, alteplase, The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefixime.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Prilocaine.]
[M04AB01, probenecid, The serum concentration of Cefixime can be increased when it is combined with Probenecid.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Procaine.]
[B01AC09, epoprostenol, The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Cefixime.]
[B01AD01, streptokinase, The therapeutic efficacy of Streptokinase can be decreased when used in combination with Cefixime.]
[B01AE07, dabigatran etexilate, The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Cefixime.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Tetracaine.]
[B01AD04, urokinase, The therapeutic efficacy of Urokinase can be decreased when used in combination with Cefixime.]
[B01AF01, rivaroxaban, The therapeutic efficacy of Rivaroxaban can be decreased when used in combination with Cefixime.]
[B01AC24, ticagrelor, The therapeutic efficacy of Ticagrelor can be decreased when used in combination with Cefixime.]
[B01AA03, warfarin, The risk or severity of bleeding can be increased when Cefixime is combined with Warfarin.]
[B01AE01, desirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.]
[B01AX01, defibrotide, The therapeutic efficacy of Defibrotide can be decreased when used in combination with Cefixime.]
[B01AF02, apixaban, The therapeutic efficacy of Apixaban can be decreased when used in combination with Cefixime.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Benzocaine.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Benzyl alcohol.]
[B01AE03, argatroban, The therapeutic efficacy of Argatroban can be decreased when used in combination with Cefixime.]
[B01AC26, vorapaxar, The therapeutic efficacy of Vorapaxar can be decreased when used in combination with Cefixime.]
[B01AA07, acenocoumarol, The risk or severity of bleeding can be increased when Cefixime is combined with Acenocoumarol.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Cefixime is combined with Dicoumarol.]
[B01AF03, edoxaban, The therapeutic efficacy of Edoxaban can be decreased when used in combination with Cefixime.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Cefixime is combined with Tioclomarol.]
[B01AC25, cangrelor, The therapeutic efficacy of Cangrelor can be decreased when used in combination with Cefixime.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Bupivacaine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Oxybuprocaine.]
[B01AF04, betrixaban, The therapeutic efficacy of Betrixaban can be decreased when used in combination with Cefixime.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Capsaicin.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Chloroprocaine.]
[B01AE02, lepirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cefixime.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Dyclonine.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cefixime.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Levobupivacaine.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Cocaine.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be decreased when used in combination with Cefixime.]
[M03AC11, cisatracurium, Cefixime may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, The therapeutic efficacy of Fondaparinux can be decreased when used in combination with Cefixime.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Cinchocaine.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Pramocaine.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Diphenhydramine.]
[B01AC07, dipyridamole, The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Cefixime.]
[B01AD10, drotrecogin alfa, The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Cefixime.]
[P03AA04, disulfiram, The risk or severity of adverse effects can be increased when Cefixime is combined with Disulfiram.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Ropivacaine.]
[B01AC18, triflusal, The therapeutic efficacy of Triflusal can be decreased when used in combination with Cefixime.]
[C05CA04, troxerutin, The therapeutic efficacy of Troxerutin can be decreased when used in combination with Cefixime.]
[B01AD03, anistreplase, The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cefixime.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Etidocaine.]
[B05AA05, dextran, The therapeutic efficacy of Dextran can be decreased when used in combination with Cefixime.]
[B01AD05, plasmin, The therapeutic efficacy of Fibrinolysin can be decreased when used in combination with Cefixime.]
[C03CA01, furosemide, Furosemide may decrease the excretion rate of Cefixime which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Cefixime is combined with Fluindione.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Cefixime.]
[B05CB02, sodium citrate, The therapeutic efficacy of Sodium citrate can be decreased when used in combination with Cefixime.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Articaine.]
[B01AE06, bivalirudin, The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cefixime.]
[B01AC22, prasugrel, The therapeutic efficacy of Prasugrel can be decreased when used in combination with Cefixime.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Cefixime.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Lidocaine.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cefixime.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Cefixime.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be decreased when used in combination with Cefixime.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Mepivacaine.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be decreased when used in combination with Cefixime.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Cefixime.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be decreased when used in combination with Cefixime.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be decreased when used in combination with Cefixime.]
[B01AD09, ancrod, The therapeutic efficacy of Ancrod can be decreased when used in combination with Cefixime.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be decreased when used in combination with Cefixime.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Cefixime is combined with Phenindione.]
[B01AA04, phenprocoumon, The risk or severity of bleeding can be increased when Cefixime is combined with Phenprocoumon.]
[B01AC13, abciximab, The therapeutic efficacy of Abciximab can be decreased when used in combination with Cefixime.]
[S01XA13, alteplase, The therapeutic efficacy of Alteplase can be decreased when used in combination with Cefixime.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Prilocaine.]
[M04AB01, probenecid, The serum concentration of Cefixime can be increased when it is combined with Probenecid.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Cefixime is combined with Procaine.]
[B01AC09, epoprostenol, The therapeutic efficacy of Epoprostenol can be decreased when used in combination with Cefixime.]
